1. Home
  2. PHAT vs NWPX Comparison

PHAT vs NWPX Comparison

Compare PHAT & NWPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAT
  • NWPX
  • Stock Information
  • Founded
  • PHAT 2018
  • NWPX 1966
  • Country
  • PHAT United States
  • NWPX United States
  • Employees
  • PHAT N/A
  • NWPX N/A
  • Industry
  • PHAT Biotechnology: Pharmaceutical Preparations
  • NWPX Steel/Iron Ore
  • Sector
  • PHAT Health Care
  • NWPX Industrials
  • Exchange
  • PHAT Nasdaq
  • NWPX Nasdaq
  • Market Cap
  • PHAT 465.0M
  • NWPX 449.0M
  • IPO Year
  • PHAT 2019
  • NWPX 1995
  • Fundamental
  • Price
  • PHAT $5.67
  • NWPX $47.81
  • Analyst Decision
  • PHAT Strong Buy
  • NWPX Buy
  • Analyst Count
  • PHAT 4
  • NWPX 2
  • Target Price
  • PHAT $23.00
  • NWPX $47.50
  • AVG Volume (30 Days)
  • PHAT 1.0M
  • NWPX 83.9K
  • Earning Date
  • PHAT 03-06-2025
  • NWPX 02-26-2025
  • Dividend Yield
  • PHAT N/A
  • NWPX N/A
  • EPS Growth
  • PHAT N/A
  • NWPX 25.64
  • EPS
  • PHAT N/A
  • NWPX 2.94
  • Revenue
  • PHAT $26,270,000.00
  • NWPX $483,085,000.00
  • Revenue This Year
  • PHAT $7,453.23
  • NWPX $13.22
  • Revenue Next Year
  • PHAT $226.38
  • NWPX $0.28
  • P/E Ratio
  • PHAT N/A
  • NWPX $16.26
  • Revenue Growth
  • PHAT N/A
  • NWPX 9.54
  • 52 Week Low
  • PHAT $5.21
  • NWPX $28.57
  • 52 Week High
  • PHAT $19.71
  • NWPX $57.76
  • Technical
  • Relative Strength Index (RSI)
  • PHAT 39.59
  • NWPX 39.90
  • Support Level
  • PHAT $5.50
  • NWPX $49.75
  • Resistance Level
  • PHAT $6.21
  • NWPX $53.46
  • Average True Range (ATR)
  • PHAT 0.40
  • NWPX 1.46
  • MACD
  • PHAT 0.07
  • NWPX -0.19
  • Stochastic Oscillator
  • PHAT 38.69
  • NWPX 5.52

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

About NWPX Northwest Pipe Company

Northwest Pipe Co is a manufacturer of water-related infrastructure products. The company has two operating segments; Engineered Steel Pressure Pipe segment manufactures large-diameter, high-pressure steel pipeline systems for use in water infrastructure applications, which are related to drinking water systems. These products are also used for hydroelectric power systems, wastewater systems, seismic resiliency, and other applications, and Precast Infrastructure and Engineered Systems segment manufacture stormwater and wastewater technology products, high-quality precast and reinforced concrete products, including manholes, box culverts, vaults, and catch basins, pump lift stations, oil water separators, biofiltration, and other environmental and engineered solutions.

Share on Social Networks: